Navigation Links
NIH grants $33 M in institutional development awards to 3 states
Date:10/29/2007

l>
  • To enhance the science and technology knowledge of the states workforce.

    Each award includes a principal investigator with established credentials relevant to the centers research theme; three to five individual research projects that share that theme and are supervised by a single junior investigator; and a development and mentoring plan that will prepare these investigators to secure competitive federal research funding.

    For states to compete on a national level for federal research dollars, we need to lay the foundation at the undergraduate level as well as partner with the local community to effect change, said NCRR Director Barbara M. Alving, M.D. By funding intellectual development and enhancing research infrastructure in these IDeA states, we are producing a pipeline of homegrown researchers who will become future leaders in competing for these federal dollars.

    New IDeA Awards:

    For full descriptions of the following IDeA centers, visit www.ncrr.nih.gov/news/2007_IDeA_Awards.asp.

    University of Kansas Medical Center (Kansas City, Kan.)
    $11 million
    Molecular Regulation of Cell Development and Differentiation
    Principal Investigator: Dale R. Abrahamson, Ph.D.

    University of Oklahoma Health Sciences Center (Oklahoma City, Okla.)
    $11 million
    Mentoring Diabetes Research in Oklahoma
    Principal Investigator: Jian-Xing Ma, M.D., Ph.D.

    Rhode Island Hospital (Providence, R.I.)
    $11 million
    Center of Biomedical Research Excellence for Skeletal Health and Repair
    Principal Investigator: Qian Chen, Ph.D.


    '/>"/>


  • Contact: NCRR Communications
    info@ncrr.nih.gov
    301-435-0888
    NIH/National Center for Research Resources  
    Source:Eurekalert

    Page: 1 2

    Related biology news :

    1. New NIAID grants strengthen national biodefense and emerging infectious diseases research network
    2. Asian immigrants in NYC not receiving HIV education at religious institutions
    3. Scientists win grants to develop $1,000 genome sequencing technology
    4. A much-needed shot in the arm for HIV vaccine development
    5. Clam embryo study shows pollutant mixture adversely affects nerve cell development
    6. Protein Packages Found To Activate Genes; May Be What Regulates Development And Disease
    7. Gene Vaccine Protects Mice Against Development Of Her2/neu Breast Cancer
    8. Development of portable infectious disease detector
    9. Zebrafish may hold key to understanding human nerve cell development
    10. Scientists identify new model Of NK cell development
    11. Influenza vaccine uses insect cells to speed development
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    Related Image:
    NIH grants $33 M in institutional development awards to 3 states
    NIH grants $33 M in institutional development awards to 3 states
    Breaking Biology Technology:Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 2Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 2Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 4Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 5Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 6Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 2Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 3Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 4Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 2Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 3Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 4